Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study (Q90426846)
Jump to navigation
Jump to search
scientific article published on 01 February 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study |
scientific article published on 01 February 2019 |
Statements
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study (English)
Carlo de Asmundis
Peter Kelly
Jean Claude Deharo
Thomas W Weiss
Johannes Waltenberger
Jan Steffel
Joris R de Groot
Pierre Levy
Ameet Bakhai
Wolfgang Zierhut
Petra Laeis
Paul-Egbert Reimitz
ETNA-AF-Europe investigators
1 February 2019